Best Tobacco Stock to Buy Right Now

 Analysis of the best U.S. tobacco stocks at the moment

1. Preferred target: Philip Morris International Inc. (PM, US stock code PM)

1.  Core Benefits:

   • Leader in new tobacco technology: The global heat-not-burn (HnB) market share is 71%, and IQOS users will grow from 22 million in 2021 to 32 million in 2024, with a compound annual growth rate of 14%.
   • Accelerated transformation of revenue structure: Smoke-free products will account for 38.8% of revenue in 2024, and it is planned to increase to more than two-thirds by 2030 to get rid of traditional cigarette dependence.
   • Barriers to globalization: Covering 84 countries or regions, core markets (such as Japan and the European Union) continue to penetrate, and IQOS has a market share of more than 30% in Japan.

2.  Finance & Growth

   • Revenue in 2024 was US$37.9 billion (+7.5%), with revenue from the new tobacco business increasing by 14.8%.
   • 2025 guidance: 12-14% growth in new tobacco shipments, 6-8% growth in net profit, and improvement in operating margin to 29-30%.
   • Dividend attractiveness: The current dividend yield is 5%, the dividend has increased by 3.9% annualized over the past 5 years, and the long-term return is stable.

3.  Catalysts and Risks

   • New product iteration: IQOS ILUMA (bladeless heating technology) is in large quantities in the European and American markets.
   • Regulatory risk: The EU taste ban may affect short-term revenues (around 6-8% in 2024), but the company responds with product upgrades.

2. Altria Group (US stock code MO): a leading company in the United States

1.  Core logic

   • E-cigarettes bucked the trend: its NJOY e-cigarette market share rose to 5.5% in 2024 (3.8% in 2023), and its shipments increased by 14.7%, challenging Juul and Vuse.
   • Traditional business resilience: Marlboro has a 43% market share of the U.S. cigarette market, and has maintained margins by raising prices.
   • Shareholder returns: $1 billion buyback program in 2024 with a dividend yield of 8.4% (one of the highest among U.S. tobacco stocks).

2.  Growth & Transformation

   • New Tobacco Bets: Plans to expand NJOY to oral nicotine (on! brand) and heated tobacco products.
   • Cost optimization: EPS growth of 3.4% in 2024 and reduction of operating expenses of $200 million.

3.  Risk Warning

   • Policy pressure: FDA may further restrict menthol cigarettes (25% of Altria’s revenue).
   • Increased competition: British American Tobacco (BAT) Vuse and PMI IQOS may enter the U.S. market.

 3. Other potential stocks

1. Universal Corporation (UVV)

   • Hidden champion in the industry: the world’s largest tobacco supplier, customers include PM, BAT and other giants.
   • Diversification: Expand the supply chain of plant-based raw materials (e.g., CBD, medicinal cannabis) and increase the proportion of non-tobacco revenue to 18% in 2024.
   • Low valuation defensive: dividend yield of 6.2%, price-to-earnings ratio of 8x, suitable for conservative investors.

2.  Vector Group (VGR)

   • High Dividend + Real Estate Hedging: Mainly engaged in low-priced cigarettes (Liggett brand) with a dividend yield of 6.8%, while holding a real estate portfolio (30% of assets).
   • Niche market advantage: Focusing on price-sensitive consumers, cigarette sales will increase by 1.2% in 2024.

 4. Industry trends and risks

1.  Core Trends

   • Accelerated penetration of new tobacco: The U.S. e-cigarette/HnB market will reach $45 billion in 2025 (up 9% year-on-year), with PM and Altria leading the technology iteration.
   • Regulatory divergence: The FDA has tightened restrictions on menthol cigarette and e-cigarette flavors, but HnB may be certified as a “harmless product” (e.g., IQOS has passed the PMTA).

2.  Key Risks

   • Policy uncertainty: FDA limits on nicotine content, federal e-cigarette tax (proposed rate of $1.01/ml) could weigh on profit margins.
   • Litigation and reputational risk: Traditional tobacco companies are still facing health lawsuits, and ESG funds continue to divest.

 Summary: Investment strategy recommendations

• Long-term growth: Philip Morris (PM) is the first choice, with leading technology and global layout to diversify risks.
• High Dividend Defensive: Altria (MO) and Vector Group (VGR) offer ultra-high dividends for income-first investors.
• Upstream and downstream opportunities in the industry: Global Tobacco (UVV) benefited from rising demand for new tobacco raw materials, with a high margin of safety in valuation.

Risk Warning: Prioritize tracking FDA policy trends (such as menthol ban schedules), corporate new tobacco shipment data, and gross profit margin changes.